PRT-064040

· Sichuan Purity Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRT-064040, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults [Phase 2]